NAD+ Anti-Ageing Studies: A Deep Dive into Cellular Health

Introduction: The Molecule That Holds the Key to Ageing

What if the secret to slowing the ageing process has been inside your cells all along? Meet NAD⁺ (nicotinamide adenine dinucleotide) – a small but mighty coenzyme found in every living cell. It fuels energy production, repairs broken DNA, and activates longevity proteins called sirtuins. But here’s the problem: NAD⁺ levels naturally decline with age, and this drop is now considered a fundamental hallmark of biological ageing.

At NAD Revival, we stay on the cutting edge of anti-ageing science. In this deep dive, we explore the most compelling studies on NAD⁺, from preclinical breakthroughs to the latest human trials, and answer the critical question: can boosting NAD⁺ truly reverse or slow the clock of ageing?

Why NAD⁺ Declines – and Why It Matters

NAD⁺ plays two essential roles in your body:

1. Energy production – It shuttles electrons inside mitochondria, helping convert food into ATP (cellular fuel).
2. Cellular repair & signalling – It serves as fuel for enzymes like sirtuins (longevity regulators) and PARPs (DNA repair crews).

As we age, three interconnected processes drive NAD⁺ down:

• Chronic inflammation – Age-related “inflammaging” activates CD38, an enzyme that consumes NAD⁺ at an accelerated rate.
• DNA damage accumulation – Broken DNA triggers PARPs, which also burn through NAD⁺.
• Declining synthesis – The salvage pathway (which recycles NAD⁺) becomes less efficient due to falling NAMPT levels.

The result? By age 50, your NAD⁺ levels can be half of what they were in your 20s. This decline is linked to metabolic dysfunction, vascular stiffness, neurodegeneration, and immune ageing.

Key Anti-Ageing Studies: From Mice to Humans

1. Preclinical Evidence – Strong and Consistent

Dozens of rodent studies show that restoring NAD⁺ improves:

• Mitochondrial function – Older mice regain youthful energy metabolism.
• DNA repair – Enhanced PARP activity reduces genomic instability.
• Neuroprotection – NAD⁺ boosters reduce motor deficits in Parkinson’s models and improve cognitive function.

In one landmark study, mice given NMN (an NAD⁺ precursor) for 12 months showed improved insulin sensitivity, bone density, and immune function – with some lifespan extension.

2. Human Trials – The Reality Check

A comprehensive 2026 systematic review (113 studies, 33 human trials) delivered both promise and caution:

• NAD⁺ precursors (NR and NMN) consistently raise NAD⁺ levels in blood – target engagement is confirmed.
• Functional outcomes are mixed – some trials show improvements in insulin sensitivity, arterial stiffness, and aerobic capacity, while others show null effects.
• Critical gap – most trials are short (weeks to months) and lack hard endpoints like disease incidence or mortality.

Bottom line: NAD⁺ boosting works biochemically, but clinical anti-ageing benefits in healthy older adults remain inconclusive – larger, longer trials are urgently needed.

Breakthrough Studies Worth Knowing

Werner Syndrome Trial (2025, Aging Cell)

In patients with Werner syndrome – a rare premature ageing disorder – oral nicotinamide riboside (NR) for 10 weeks:

• Increased blood NAD⁺ by 140%
• Improved arterial stiffness (a cardiovascular risk marker)
• Reduced skin ulcer area
• Slowed kidney function decline

This is the first randomised controlled trial showing NAD⁺ supplementation improves multiple ageing-related outcomes in humans.

CD38 Inhibition – A New Frontier

Instead of just adding precursors, researchers are now blocking NAD⁺ consumers. A potent CD38 inhibitor called 78c reversed age-related NAD⁺ loss in mice, improving glucose tolerance, heart function, and exercise capacity – without the need for high-dose supplementation.

The Bioavailability Problem

A 2023 trial in Cell Metabolism found that while oral NR raised whole‑blood NAD⁺ by 40–90%, it failed to increase muscle NAD⁺ in healthy adults. This highlights a key challenge: raising NAD⁺ in the blood doesn’t guarantee delivery to tissues like muscle, brain, or heart – where anti‑ageing effects matter most.

Safety and Tolerability

Across all human trials, NAD⁺ precursors (NR, NMN, nicotinamide) have demonstrated an excellent safety profile:

• No serious adverse events reported in short- to medium-term studies.
• Mild side effects (flushing, nausea) are rare with newer precursors.

However, long-term safety (years of use) is not yet established. Preclinical concerns about potentially fueling cancer cell growth (since cancer cells also need NAD⁺) remain unresolved and require monitoring.

What This Means for You – The NAD Revival Perspective

At NAD Revival, we believe in science-backed strategies. Here’s how to interpret the evidence today:

1. NAD⁺ boosting is biologically sound – The mechanism is real, and human studies confirm target engagement.
2. Results vary by individual – Genetics, age, baseline NAD⁺ levels, and tissue bioavailability all matter.
3. Lifestyle synergies still reign – Exercise, intermittent fasting, and caloric restriction naturally raise NAD⁺. Supplements work best alongside these habits.
4. Future is combination therapy – The most effective anti-ageing protocol will likely pair NAD⁺ precursors with senolytics (that clear senescent cells), CD38 inhibitors, and precision nutrition.

The Bottom Line: Promise, Not Yet Proof

NAD⁺ science is one of the most exciting frontiers in longevity research. The molecule sits at the nexus of energy, repair, and resilience. Preclinical studies are overwhelmingly positive, and human trials confirm we can safely raise NAD⁺ levels.

But the leap from raising NAD⁺ to proven anti-ageing in healthy people has not yet been fully crossed. We need larger, longer, and better-designed trials with real-world endpoints – fewer falls, less cognitive decline, longer healthspan.

Until then, NAD⁺ precursors are a promising, low-risk investment in your cellular health – especially if you combine them with a healthy lifestyle. At NAD Revival, we’ll keep tracking the science and bringing you the latest breakthroughs.

Ready to learn more? Explore our NAD⁺ precursor guides and stay updated on the latest anti-ageing research.

References (Key Studies Mentioned):

• 2026 systematic review: NAD⁺ supplementation for anti‑ageing – 113 studies.
• Werner syndrome NR trial – Aging Cell, 2025.
• CD38 inhibitor 78c – reverses NAD⁺ loss in aged mice.
• Bioavailability trial – Cell Metabolism, 2023.